JD Health International Inc. (HKG:6618)
63.45
+0.40 (0.63%)
Sep 3, 2025, 2:45 PM HKT
JD Health International Revenue
JD Health International had revenue of 35.29B CNY in the half year ending June 30, 2025, with 30.17% growth. This brings the company's revenue in the last twelve months to 65.11B, up 18.89% year-over-year. In the year 2024, JD Health International had annual revenue of 58.16B with 8.65% growth.
Revenue (ttm)
65.11B CNY
Revenue Growth
+18.89%
P/S Ratio
2.83
Revenue / Employee
18.27M CNY
Employees
3,564
Market Cap
201.85B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 58.16B | 4.63B | 8.65% |
Dec 31, 2023 | 53.53B | 6.79B | 14.54% |
Dec 31, 2022 | 46.74B | 16.05B | 52.32% |
Dec 31, 2021 | 30.68B | 11.30B | 58.30% |
Dec 31, 2020 | 19.38B | 8.54B | 78.77% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
BeOne Medicines | 35.81B |
Hansoh Pharmaceutical Group Company | 14.45B |
Innovent Biologics | 12.52B |
Sino Biopharmaceutical | 33.49B |
WuXi Biologics | 21.98B |
Akeso | 2.75B |
CSPC Pharmaceutical Group | 28.49B |
Sichuan Kelun-Biotech Biopharmaceutical | 1.64B |